Legal Representation
Attorney
Jeffrey Klembczyk
USPTO Deadlines
Next Deadline
58 days remaining
NOA E-Mailed - SOU Required
Due Date
September 04, 2025
Extension Available
Until March 04, 2026
Application History
14 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 16, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 16, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Apr 16, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 16, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Apr 16, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Apr 16, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Mar 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 7, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 7, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 1, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 22, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 9, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Providing online non-downloadable software for gathering and analyzing data of patients undergoing infusion therapy; providing online non-downloadable software for gathering data of patients undergoing infusion therapy and benchmarking such data; providing online non-downloadable software for gathering data of patients undergoing infusion therapy and benchmarking such data against aggregated infusion therapy data; software as a service (SAAS) services featuring web services application programming interface (API) software for enabling users to query infusion therapy data for analysis and comparison with aggregated infusion therapy data; software as a service (SAAS) services featuring software for gathering data of patients undergoing infusion therapy and benchmarking such data against aggregated infusion therapy data.
Classification
International Classes
042